Search

Issue
Title
Authors
Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer
Zhukova L.G., Artamonova E.V., Ganshina I.P., Kolyadina I.V., Vorontsova K.A., Sekhina O.V., Grechukhina K.S.
Adjuvant and neoadjuvant therapy for (based on the materials of the 16th St. Gallen International Breast Cancer Conference)
Semiglazov V.F., Semiglazov V.V.
De-escalation and escalation of treatment of patients with HER2-positive breast cancer
Semiglazov V.F., Semiglazov V.V., Nikolaev K.S., Komyakhov A.V., Semiglazova T.Y., Paltoev R.M., Donskikh R.V., Tseluyko A.I., Artemyeva A.S., Bashlyk V.O., Miryusupova G.F., Dashyan G.A.
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Semiglazov V.F., Semiglazov V.V., Dashyan G.A., Krivorotko P.V., Nikolaev K.S., Semiglazova T.Y., Komyakhov A.V., Bessonov A.A., Donskikh R.V., Paltuev R.M., Zernov K.Y.
Pertuzumab - novyy vzglyad na HER2-polozhitel'nyy metastaticheskiy rak molochnoy zhelezy
Gan'shina I.P., Zhukova L.G., Tyurin I.E.
DVOYNAYa BLOKADA HER2-PETsEPTOPA - NOVOE NAPRAVLENIE V LEChENII RAKA MOLOChNOY ZhELEZY S GIPEREKSPRESSIEY HER2
Gan'shina I.P., Lubennikova E.V., Zhukova L.G.
NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Gorbunova V.A.
1 - 7 of 7 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies